Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis

Authors: Glenn Haugeberg, Inger Johanne W Hansen, Tone Skarpaas, Sølvi Noraas, Vivian Kjelland

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Despite Southern Norway is an endemic area for Lyme borreliosis there is a lack of data on Lyme arthritis (LA). In the literature controversies exist if acute LA can develop into chronic arthritis. Our objective was to identify and characterize patients with LA in Southern Norway and explore disease course after antibiotic treatment.

Methods

Patients aged 20 years or older with arthritis and a positive serology for Borrelia burgdorferi infection (IgG and/or IgM) suspected of having LA were consecutively recruited either from general practitioners or from hospital departments.

Results

From January 2007 to December 2010 a total of 27 patients were assessed. Mean (range) age was 56 years (41–80) and mean symptom duration prior to inclusion was 11.2 weeks (1 day – 2 years). Definite LA was diagnosed in 16 patients, probable LA in 5 patients and 6 patients were concluded to have other arthritis disorders. Among the 21 LA patients 20 had mono-arthritis (knee 18, ankle 2) and 1 had polyarthritis.
All LA patients responded favourable to antibiotic treatment and none of the patients developed chronic arthritis after long term follow up, not even in LA patients who had intraarticular glucocorticosteroid (GC) injection prior to antibiotic treatment.

Conclusions

Our data shows that LA in Southern Norway is a benign disease which successfully can be treated with antibiotics even in patients treated with GC prior to antibiotics.
Literature
2.
go back to reference Nygard K, Brantsaeter AB, Mehl R: Disseminated and chronic Lyme borreliosis in Norway, 1995–2004. European communicable disease bulletin. 2005, 10: 235-238. Nygard K, Brantsaeter AB, Mehl R: Disseminated and chronic Lyme borreliosis in Norway, 1995–2004. European communicable disease bulletin. 2005, 10: 235-238.
3.
go back to reference Kjelland V, Stuen S, Skarpaas T, Slettan A: Prevalence and genotypes of Borrelia burgdorferi sensu lato infection in Ixodes ricinus ticks in southern Norway. Scand J Infect Dis. 2010, 42: 579-585. 10.3109/00365541003716526.CrossRefPubMed Kjelland V, Stuen S, Skarpaas T, Slettan A: Prevalence and genotypes of Borrelia burgdorferi sensu lato infection in Ixodes ricinus ticks in southern Norway. Scand J Infect Dis. 2010, 42: 579-585. 10.3109/00365541003716526.CrossRefPubMed
4.
go back to reference Mygland A, Skarpaas T, Ljostad U: Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006, 13: 1213-1215. 10.1111/j.1468-1331.2006.01395.x.CrossRefPubMed Mygland A, Skarpaas T, Ljostad U: Chronic polyneuropathy and Lyme disease. Eur J Neurol. 2006, 13: 1213-1215. 10.1111/j.1468-1331.2006.01395.x.CrossRefPubMed
5.
go back to reference Skarpaas T, Ljostad U, Sobye M, Mygland A: Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis. 2007, 26: 675-677. 10.1007/s10096-007-0336-y.CrossRefPubMed Skarpaas T, Ljostad U, Sobye M, Mygland A: Sensitivity and specificity of a commercial C6 peptide enzyme immuno assay in diagnosis of acute Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis. 2007, 26: 675-677. 10.1007/s10096-007-0336-y.CrossRefPubMed
6.
go back to reference Ljostad U, Okstad S, Topstad T, Mygland A, Monstad P: Acute peripheral facial palsy in adults. J Neurol. 2005, 252: 672-676. 10.1007/s00415-005-0715-1.CrossRefPubMed Ljostad U, Okstad S, Topstad T, Mygland A, Monstad P: Acute peripheral facial palsy in adults. J Neurol. 2005, 252: 672-676. 10.1007/s00415-005-0715-1.CrossRefPubMed
7.
go back to reference Ljostad U, Skarpaas T, Mygland A: Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol. 2007, 14: 873-876. 10.1111/j.1468-1331.2007.01799.x.CrossRefPubMed Ljostad U, Skarpaas T, Mygland A: Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol. 2007, 14: 873-876. 10.1111/j.1468-1331.2007.01799.x.CrossRefPubMed
8.
go back to reference Ljostad U, Mygland A, Skarpaas T: Neuroborreliosis in Vest-Agder. Tidsskr Nor Laegeforen. 2003, 123: 610-613.PubMed Ljostad U, Mygland A, Skarpaas T: Neuroborreliosis in Vest-Agder. Tidsskr Nor Laegeforen. 2003, 123: 610-613.PubMed
9.
go back to reference Feder HM, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP: A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007, 357: 1422-1430. 10.1056/NEJMra072023.CrossRefPubMed Feder HM, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP: A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007, 357: 1422-1430. 10.1056/NEJMra072023.CrossRefPubMed
10.
go back to reference Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH, Liu NY, Schmid CH: Treatment of Lyme arthritis. Arthritis Rheum. 1994, 37: 878-888. 10.1002/art.1780370616.CrossRefPubMed Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH, Liu NY, Schmid CH: Treatment of Lyme arthritis. Arthritis Rheum. 1994, 37: 878-888. 10.1002/art.1780370616.CrossRefPubMed
11.
go back to reference Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG: An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci U S A. 2004, 101: 18159-18164. 10.1073/pnas.0405763102.CrossRefPubMedPubMedCentral Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG: An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci U S A. 2004, 101: 18159-18164. 10.1073/pnas.0405763102.CrossRefPubMedPubMedCentral
12.
go back to reference Portnoi D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D: A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence. FEMS Microbiol Lett. 2006, 259: 35-40. 10.1111/j.1574-6968.2006.00249.x.CrossRefPubMed Portnoi D, Sertour N, Ferquel E, Garnier M, Baranton G, Postic D: A single-run, real-time PCR for detection and identification of Borrelia burgdorferi sensu lato species, based on the hbb gene sequence. FEMS Microbiol Lett. 2006, 259: 35-40. 10.1111/j.1574-6968.2006.00249.x.CrossRefPubMed
13.
go back to reference Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG: Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology. 2004, 150: 1741-1755. 10.1099/mic.0.26944-0.CrossRefPubMed Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG: Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology. 2004, 150: 1741-1755. 10.1099/mic.0.26944-0.CrossRefPubMed
14.
go back to reference Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM: Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 1977, 20: 7-17. 10.1002/art.1780200102.CrossRefPubMed Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM: Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 1977, 20: 7-17. 10.1002/art.1780200102.CrossRefPubMed
15.
go back to reference Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med. 1987, 107: 725-731. 10.7326/0003-4819-107-5-725.CrossRefPubMed Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med. 1987, 107: 725-731. 10.7326/0003-4819-107-5-725.CrossRefPubMed
16.
go back to reference MSIS: The Norwegian Surveillance System for Communicable Diseases (MSIS). 2007–2010, Norway: Norwegian Institute of Public Health MSIS: The Norwegian Surveillance System for Communicable Diseases (MSIS). 2007–2010, Norway: Norwegian Institute of Public Health
17.
go back to reference Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP: Estimation of the incidence of Lyme disease. Am J Epidemiol. 1998, 148: 1018-1026. 10.1093/oxfordjournals.aje.a009568.CrossRefPubMed Campbell GL, Fritz CL, Fish D, Nowakowski J, Nadelman RB, Wormser GP: Estimation of the incidence of Lyme disease. Am J Epidemiol. 1998, 148: 1018-1026. 10.1093/oxfordjournals.aje.a009568.CrossRefPubMed
18.
go back to reference Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP: Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis. 2011, 11: 713-719. 10.1016/S1473-3099(11)70034-2.CrossRefPubMedPubMedCentral Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP: Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis. 2011, 11: 713-719. 10.1016/S1473-3099(11)70034-2.CrossRefPubMedPubMedCentral
19.
go back to reference Ljostad U, Mygland A: The phenomenon of 'chronic Lyme'; an observational study. Eur J Neurol. 2012, 19: 1128-1135. 10.1111/j.1468-1331.2012.03691.x.CrossRefPubMed Ljostad U, Mygland A: The phenomenon of 'chronic Lyme'; an observational study. Eur J Neurol. 2012, 19: 1128-1135. 10.1111/j.1468-1331.2012.03691.x.CrossRefPubMed
20.
go back to reference Bentas W, Karch H, Huppertz HI: Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol. 2025–2030, 2000: 27- Bentas W, Karch H, Huppertz HI: Lyme arthritis in children and adolescents: outcome 12 months after initiation of antibiotic therapy. J Rheumatol. 2025–2030, 2000: 27-
Metadata
Title
Lyme arthritis in Southern Norway - an endemic area for Lyme Borreliosis
Authors
Glenn Haugeberg
Inger Johanne W Hansen
Tone Skarpaas
Sølvi Noraas
Vivian Kjelland
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-185

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine